This was the first study to investigate the impact of oxytocin on emotion recognition, trusting behaviour, affect, anxiety and body satisfaction, and the moderating effects of ED symptoms, by comparing participants randomly allocated to receive a single dose of either 24 IU of oxytocin or placebo intranasal spray. The gene discussed is OXT; the disease is Anxiety.